Amin Makarem

Stock Analyst at Jefferies

(1.99)
# 3,255
Out of 4,595 analysts
2
Total ratings
50%
Success rate
42.8%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Amin Makarem

UroGen Pharma
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $38.24
Upside: +4.60%
Foghorn Therapeutics
Feb 16, 2026
Maintained: Buy
Price Target: $12
Current: $4.53
Upside: +164.90%